ERBB2 and breast neoplasm: Interestingly, we found that, among the 35 autophagy genes analyzed, upregulation of only ATG12 or MAP1LC3B in ERBB2-positive breast tumors leads to lower RFS-based patient survival probability, whereas ATG12 or MAP1LC3B upregulation has no effect on the survival probability of patients with ERBB2-negative breast tumors, in contrast to the cases with upregulation of BECN1 and other genes (Figure 5 and Table S1).